Korro Bio | 424B3: Prospectus
Korro Bio | 424B3: Prospectus
Korro Bio | 8-K: Current report
Korro Bio | 4: Statement of changes in beneficial ownership of securities-Officer Cerio Jeffrey
Korro Bio | 3: Initial statement of beneficial ownership of securities-Officer Cerio Jeffrey
Korro Bio | 144: Notice of proposed sale of securities pursuant to Rule 144
Korro Bio | 4: Statement of changes in beneficial ownership of securities-Director Knobil Katharine
Korro Bio | 3: Initial statement of beneficial ownership of securities-Director Knobil Katharine
Korro Bio | 424B3: Prospectus
Korro Bio | 8-K: Current report
Korro Bio | 424B3: Prospectus
Korro Bio | 424B3: Prospectus
Korro Bio | 424B3: Prospectus
Korro Bio | 10-Q: Q2 2024 Earnings Report
Korro Bio | 8-K: Korro Reports Second Quarter 2024 Financial Results and Provides Business Updates
Korro Bio | SC 13G/A: Statement of acquisition of beneficial ownership by individuals (Amendment)-Invus Public Equities, L.P.(4.5%),Invus Public Equities Advisors, LLC(4.5%), etc.
Korro Bio | 424B3: Prospectus
Korro Bio | 424B3: Prospectus
Korro Bio | 8-K: Current report
Korro Bio | 424B3: Prospectus
No Data
No Data